Biogen Announces License Agreement With Alcyone For ThecaFlex DRx System

Biogen Inc. (BIIB) Wednesday announced a license and collaboration agreement with Alcyone Therapeutics to develop ThecaFlex DRx System, an implantable medical device. Biogen will make an upfront payment of $10 million to Alcyone for an exclusive global license to the ThecaFlex DRx and will be eligible for up to $41 million in potential milestone payments.

Biogen said Alcyone's ThecaFlex DRx is intended for subcutaneous delivery of antisense oligonucleotide therapies into the intrathecal space. The ThecaFlex DRx System is expected to help improve the patient treatment experience for spinal muscular atrophy and amyotrophic lateral sclerosis.

The ThecaFlex DRx System has received a CE Mark in Europe and has received Breakthrough Device Designation from the U.S. Food and Drug Administration.

As per the agreement, Alcyone will be solely responsible for its manufacture and commercialization.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ford Motor Co. has once again raised the price of its popular F-150 Lightning electric pickup truck after the automaker resumed its production that was halted following electric vehicle battery fire incident. The company will also resume shipments of the Lightning this week, reports said. Paducah, Kentucky-based Higdon Outdoors LLC is recalling certain battery packs and replacement batteries citing fire and/or burn hazards, the U.S. Consumer Product Safety Commission said. The recall includes lithium-ion battery packs and replacement batteries on XS Series Pulsators, Swimmers, Crazy Kicker, and Flasher motion decoys used for waterfowl hunting. New York-based Delta Enterprise Corp. is recalling about 43,380 units of 2-in-1 outdoor kids swings citing fall hazard, the U.S. Consumer Product Safety Commission said. This recall involves 2-in-1 Outdoor Kids Swing with model numbers SW86508MM, SW86516MN, SW86575MM, SW86576MN and SW86577PW.
Follow RTT